Navigation Links
Mushrooms may aid rapid vaccine response

A rapid production of therapeutic human drugs using modified mushrooms may help mount a quicker response to various public health problems, according to plant pathologists who have received a federal grant to perfect their technique.

C. Peter Romaine, professor of plant pathology at Penn State and holder of the John B. Swayne Chair in Spawn Science, said, "We are looking to address several public health issues through our research."

Romaine and his colleague, Xi Chen, previously a post-doctoral scholar at Penn State, hold the patent to genetically modify Agaricus bisporus the button variety of mushroom, which is the predominant edible species worldwide.

The Defense Advanced Research Projects Agency (DARPA) recently awarded Penn State and Agarigen Inc., Romaine's spin-off company based in Research Triangle Park in Raleigh, N.C., $2.2 million in initial funding under the Accelerated Manufacture of Pharmaceuticals (AMP) program for the rapid production of vaccines and other therapeutic proteins in altered mushrooms. The total value of the effort, if both phases of the development program are completed, could be up to $5.9 million.

"Our immediate research goals are to maximize the level of expression of various biopharmaceuticals and to devise efficient and economical methods for their extraction and purification from mushroom tissue," Romaine said.

At the end of the second year of the contract, Romaine and his colleagues, who include Agarigen cofounder and former Penn State graduate Dr. Donald S. Walters, Penn State post doctoral associate Dr. Carl Schlagnhaufer and a team of nine Agarigen scientists, are expected to demonstrate an ability to produce vaccines or other biological drugs within 12 weeks.

"It will be a blind test," said Romaine. "We will be handed genes for vaccines, monoclonal antibodies or other therapeutic proteins, and asked to produce them in the mushroom."

The drugs will then be extracted from the mushroom into forms that could be administered to people. In a pending third year of the project, the researchers are expected to show they can execute a full-scale manufacturing effort and produce three million doses of a drug in 12 weeks.

Researchers at Penn State and Agarigen are currently focusing on assembling gene components for expression in the mushroom, and fine-tuning their techniques to ensure a consistently high level and quality of the drug.

"We are evaluating different gene sequences from a broad array of organisms to determine which provide us the highest level of drug expression in the mushroom," explained Romaine. "It is an empirical process, but we are leaving no stone unturned to achieve our end goal."


Contact: Amitabh Avasthi
Penn State

Related medicine news :

1. Study documents rapid increase in youth bipolar disorder diagnoses
2. Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
3. Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation
4. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
5. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
6. AWT, Inc. Continues Rapid Expansion in Middle East
7. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
8. Rapid Pathogen Screening Announces New Vice President of Corporate Relations
9. Varian Medical Systems to Introduce RapidArc(TM) Radiotherapy Technology for Volumetric Arc Therapy at ASTRO 2007
10. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
11. HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053
Post Your Comments:
(Date:11/30/2015)... ... 30, 2015 , ... GKhair & Tibolli team members and artists were excited ... on November 8th and 9th at the Puerto Rico Convention Center, San Juan Puerto ... and top of the line fashion journalists. The San Juan Beauty Show carries immense ...
(Date:11/30/2015)... ... November 30, 2015 , ... Winscribe ... at the Radiological Society of North America (RSNA) 2015 conference. , Leading ... cutting-edge dictation and speech-enabled documentation software, announced their partnership today at RSNA ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announces the Unstoppable Swappables, a household invention that provides an economical and easy ... a year and is growing at 2.6%," says Scott Cooper, CEO and Creative ...
(Date:11/29/2015)... ... November 29, 2015 , ... ... Institute of Ultrasound in Medicine! , AIUM ultrasound practice accreditation is a ... or exceed nationally recognized standards in the performance and interpretation of diagnostic ...
(Date:11/29/2015)... Ca (PRWEB) , ... November 29, 2015 , ... Khanna ... American Board of Ophthalmology on November 25th 2015. Peer Certification by the ... field of his specialty. Certification in Ophthalmology is first obtained after the completion of ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
(Date:11/26/2015)... 26, 2015 --> ... SyMRI to find optimal contrast weighting of MRI for ... has signed a research agreement with SyntheticMR in order to ... SyMRI, it is possible to generate multiple contrast images from ... patient has left, thus making it possible to both fine ...
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
Breaking Medicine Technology: